InnoCare Issues 0.58 Million New RMB Shares Under 2024 Incentive Scheme; Hong Kong Share Count Unchanged

Bulletin Express09-17 17:06

InnoCare Pharma Limited reported a minor change in its share capital following the attribution of the first tranche of the 2024 RMB Share Incentive Scheme. On 17 September 2026, the company issued 581,137 new RMB-denominated ordinary shares to 86 scheme participants at RMB 6.65 per share.

The issuance, listed on the Science and Technology Innovation Board of the Shanghai Stock Exchange, increased the RMB share count to 273.40 million from 272.82 million—an incremental dilution of 0.03 %.

No changes occurred in the Hong Kong-listed share class, which remains at 1.49 billion ordinary shares. Consequently, InnoCare’s combined share capital across both markets now stands at approximately 1.77 billion shares.

The board confirms that the share allotment complied with all applicable regulatory and listing requirements. No share repurchases, cancellations or on-market sales of treasury shares were reported during the period.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1102911969?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-17 17:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1102911969","market":"hk","top_or_hot":-1,"title":"InnoCare Issues 0.58 Million New RMB Shares Under 2024 Incentive Scheme; Hong Kong Share Count Unchanged","media":"Bulletin Express","content":"<p>InnoCare Pharma Limited reported a minor change in its share capital following the attribution of the first tranche of the 2024 RMB Share Incentive Scheme. On 17 September 2026, the company issued 581,137 new RMB-denominated ordinary shares to 86 scheme participants at RMB 6.65 per share.</p>\n<p>The issuance, listed on the Science and Technology Innovation Board of the Shanghai Stock Exchange, increased the RMB share count to 273.40 million from 272.82 million—an incremental dilution of 0.03 %.</p>\n<p>No changes occurred in the Hong Kong-listed share class, which remains at 1.49 billion ordinary shares. Consequently, InnoCare’s combined share capital across both markets now stands at approximately 1.77 billion shares.</p>\n<p>The board confirms that the share allotment complied with all applicable regulatory and listing requirements. No share repurchases, cancellations or on-market sales of treasury shares were reported during the period.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>InnoCare Issues 0.58 Million New RMB Shares Under 2024 Incentive Scheme; Hong Kong Share Count Unchanged</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInnoCare Issues 0.58 Million New RMB Shares Under 2024 Incentive Scheme; Hong Kong Share Count Unchanged\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-09-17 17:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>InnoCare Pharma Limited reported a minor change in its share capital following the attribution of the first tranche of the 2024 RMB Share Incentive Scheme. On 17 September 2026, the company issued 581,137 new RMB-denominated ordinary shares to 86 scheme participants at RMB 6.65 per share.</p>\n<p>The issuance, listed on the Science and Technology Innovation Board of the Shanghai Stock Exchange, increased the RMB share count to 273.40 million from 272.82 million—an incremental dilution of 0.03 %.</p>\n<p>No changes occurred in the Hong Kong-listed share class, which remains at 1.49 billion ordinary shares. Consequently, InnoCare’s combined share capital across both markets now stands at approximately 1.77 billion shares.</p>\n<p>The board confirms that the share allotment complied with all applicable regulatory and listing requirements. No share repurchases, cancellations or on-market sales of treasury shares were reported during the period.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09969","symbol_name":"诺诚健华","start_time":0,"source_url":"","article_id":"1102911969","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1102911969","pubTimestamp":1789635974,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"InnoCare Pharma Limited reported a minor change in its share capital following the attribution of the first tranche of the 2024 RMB Share Incentive Scheme. On 17 September 2026, the company issued...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09969":"诺诚健华"},"translate_title":"诺诚健华根据2024年激励计划发行58万股人民币新股；香港股份数目不变","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09969":1},"content_text":"InnoCare Pharma Limited reported a minor change in its share capital following the attribution of the first tranche of the 2024 RMB Share Incentive Scheme. On 17 September 2026, the company issued 581,137 new RMB-denominated ordinary shares to 86 scheme participants at RMB 6.65 per share.\nThe issuance, listed on the Science and Technology Innovation Board of the Shanghai Stock Exchange, increased the RMB share count to 273.40 million from 272.82 million—an incremental dilution of 0.03 %.\nNo changes occurred in the Hong Kong-listed share class, which remains at 1.49 billion ordinary shares. Consequently, InnoCare’s combined share capital across both markets now stands at approximately 1.77 billion shares.\nThe board confirms that the share allotment complied with all applicable regulatory and listing requirements. No share repurchases, cancellations or on-market sales of treasury shares were reported during the period.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.0","shortVersion":"4.50.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1102911969","isCrawlerRequest":true}